The buyback boom returns, even as CFOs whisper about a 2027 capex cycle

NEW YORK — Share repurchases are back in fashion, which is another way of saying corporate America is still more confident in its own stock than in its next factory. Authorization announcements have picked up through 2026, concentrated in technology, financials, and the parts of healthcare that generate more cash than ideas. The political noise around buybacks has not disappeared. It has been priced in as a cost of doing capital allocation in public.

The tension sits in the 2027 sketches that CFOs keep attaching to their prepared remarks. AI-related data-center power, grid interconnects, semiconductor tools, and a delayed industrial refresh are all being described as "visible but not this year's problem." That is a polite way of saying the board would like the stock higher before the capex cycle makes free cash flow look worse.

There is nothing inherently cynical about that sequence. There is something fragile about it. If the cost of capital stays higher for longer, the same companies will be asked why they retired equity instead of pre-funding a build they now describe as strategic. If the cycle slips, they will be praised for discipline. Timing, as ever, is the entire job.

Investors should separate mechanical buybacks — offsetting dilution from compensation — from the large, discretionary programs that are a bet on multiple. The first is hygiene. The second is a house view on 2027. TradeFlock will be watching which CFOs still sound casual about that view once the first transformer lead times show up in the 10-K.